Spyre Therapeutics, Inc. - COM NEW (SYRE)

Historical Portfolio Holders from Q3 2023 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM NEW
Shares, excl. options Q1 2024
31.6 M
Holdings value Q1 2024
$1.2 B
Value change Q1 2024
+$171 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
99
Number of buys Q1 2024
71
Number of sells Q1 2024
-21
Average buys Q1 2024 %
+0.002%
Average sells Q1 2024 %
-0.004%
CUSIP
00773J202
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 31.6 M $1.2 B +$171 M $37.93 99
2023 Q4 28 M $601 M +$524 M $21.52 53
2023 Q3 3.26 M $39.9 M +$39.9 M $12.25 27